Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123550722 | 12355072 | 2 | F | 20150729 | 20160729 | 20160511 | 20160810 | EXP | CA-PFIZER INC-2015306460 | PFIZER | 41.00 | YR | M | Y | 0.00000 | 20160810 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123550722 | 12355072 | 1 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 2 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 3 | SS | ETANERCEPT | ETANERCEPT | 1 | U | 0 | |||||||||||
| 123550722 | 12355072 | 4 | PS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | U | 7073 | |||||||||
| 123550722 | 12355072 | 5 | SS | INFLIXIMAB HOSPIRA | INFLIXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 6 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 8 | SS | CERTOLIZUMAB PEGOL | CERTOLIZUMAB PEGOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 9 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 10 | SS | USTEKINUMAB | USTEKINUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 11 | SS | APREMILAST | APREMILAST | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 123550722 | 12355072 | 12 | SS | CYCLOSPORINE A | CYCLOSPORINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 123550722 | 12355072 | 13 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 123550722 | 12355072 | 14 | SS | MOTRIN | IBUPROFEN | 1 | Oral | 600 MG, EVERY 3-4 HOURS REGULARLY | 0 | 600 | MG | ||||||||
| 123550722 | 12355072 | 15 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | U | 0 | |||||||||||
| 123550722 | 12355072 | 16 | SS | STELARA | USTEKINUMAB | 1 | U | 0 | |||||||||||
| 123550722 | 12355072 | 17 | SS | OTEZLA | APREMILAST | 1 | UNK | U | 0 | TABLET | |||||||||
| 123550722 | 12355072 | 18 | C | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 10 MG, WEEKLY (2.5 MG - 4 TABLETS ONCE A WEEK) | 0 | 10 | MG | TABLET | /wk | |||||||
| 123550722 | 12355072 | 19 | C | OXYNEO | OXYCODONE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 123550722 | 12355072 | 20 | C | OXYNEO | OXYCODONE | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 123550722 | 12355072 | 21 | C | MOGADON | NITRAZEPAM | 1 | 5 MG, UNK | 0 | 5 | MG | TABLET | ||||||||
| 123550722 | 12355072 | 22 | C | ULORIC | FEBUXOSTAT | 1 | 80 MG, TWICE A DAY | 0 | 80 | MG | BID | ||||||||
| 123550722 | 12355072 | 23 | C | COLCHICINE. | COLCHICINE | 1 | 0.6 MG, UNK | 0 | .6 | MG | |||||||||
| 123550722 | 12355072 | 24 | C | ACIDE FOLIQUE | FOLIC ACID | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123550722 | 12355072 | 1 | Psoriatic arthropathy |
| 123550722 | 12355072 | 2 | Rheumatoid arthritis |
| 123550722 | 12355072 | 3 | Psoriasis |
| 123550722 | 12355072 | 4 | Product used for unknown indication |
| 123550722 | 12355072 | 5 | Psoriatic arthropathy |
| 123550722 | 12355072 | 6 | Psoriatic arthropathy |
| 123550722 | 12355072 | 7 | Psoriatic arthropathy |
| 123550722 | 12355072 | 8 | Psoriatic arthropathy |
| 123550722 | 12355072 | 9 | Psoriatic arthropathy |
| 123550722 | 12355072 | 10 | Psoriatic arthropathy |
| 123550722 | 12355072 | 11 | Psoriatic arthropathy |
| 123550722 | 12355072 | 12 | Product used for unknown indication |
| 123550722 | 12355072 | 13 | Product used for unknown indication |
| 123550722 | 12355072 | 14 | Product used for unknown indication |
| 123550722 | 12355072 | 15 | Psoriatic arthropathy |
| 123550722 | 12355072 | 16 | Psoriatic arthropathy |
| 123550722 | 12355072 | 17 | Psoriatic arthropathy |
| 123550722 | 12355072 | 19 | Product used for unknown indication |
| 123550722 | 12355072 | 21 | Product used for unknown indication |
| 123550722 | 12355072 | 22 | Product used for unknown indication |
| 123550722 | 12355072 | 23 | Product used for unknown indication |
| 123550722 | 12355072 | 24 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123550722 | 12355072 | DS |
| 123550722 | 12355072 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123550722 | 12355072 | Activities of daily living impaired | |
| 123550722 | 12355072 | Alanine aminotransferase increased | |
| 123550722 | 12355072 | Aspartate aminotransferase increased | |
| 123550722 | 12355072 | C-reactive protein abnormal | |
| 123550722 | 12355072 | Drug hypersensitivity | |
| 123550722 | 12355072 | Drug intolerance | |
| 123550722 | 12355072 | Enthesopathy | |
| 123550722 | 12355072 | Erythema | |
| 123550722 | 12355072 | Headache | |
| 123550722 | 12355072 | Nausea | |
| 123550722 | 12355072 | Tenosynovitis | |
| 123550722 | 12355072 | Tongue disorder | |
| 123550722 | 12355072 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |